US 11400096
Small molecules for the treatment of autoimmune disorders
granted A61KA61K31/52A61K31/522
Quick answer
US patent 11400096 (Small molecules for the treatment of autoimmune disorders) held by The Board of Regents of the University of Texas System expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/52, A61K31/522